News

Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and ...
Intel Ohio One is now five years from completion, but investors are watching new Intel CEO Lip-Bu Tan closely to see where he ...